Delta Investment Management »

C4 Therapeutics shares owned by Delta Investment Management

Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Delta Investment Management from 13F filings

Historical chart of Delta Investment Management investment in C4 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including C4 Therapeutics held by Delta Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in C4 Therapeutics by Delta Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $38k 20k 1.91
2024-12-31 $72k 20k 3.60

More positions owned by Delta Investment Management

Microsoft Corporation (MSFT)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Invesco Exch Trd Slf Idx Invsco Blsh 26 (BSJQ)
Innovator Etfs Trust Quity Managd Flr (SFLR)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Listed Fds Tr Overlay Shares (OVLH)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Anthem (ELV)
Pimco Etf Tr Multisector Bd (PYLD)
TransDigm Group Incorporated (TDG)

View all positions for Delta Investment Management

Top funds holding C4 Therapeutics

Lynx1 Capital Management
Soleus Capital Management
OrbiMed Advisors
Daniel D. Thurber
Vanguard Group
Millennium Management
Silverarc Capital Management
BlackRock
Bain Capital Life Sciences Investors
Renaissance Technologies
Tang Capital Management
Two Sigma Investments
Two Sigma Advisers
Geode Capital Management
Susquehanna International

View all funds holding C4 Therapeutics